4.2 Article

Controlling Nutritional Status score: A new prognostic indicator for patients with oligometastatic prostate cancer

Journal

CURRENT PROBLEMS IN CANCER
Volume 43, Issue 5, Pages 461-470

Publisher

MOSBY-ELSEVIER
DOI: 10.1016/j.currproblcancer.2019.02.001

Keywords

Oligometastasis; Prostate cancer; CONUT score; PLR; NLR

Categories

Funding

  1. National Natural Science Foundation of China [81472389]

Ask authors/readers for more resources

The Controlling Nutritional Status (CONUT) score is associated with prognosis in a variety of cancers, but the association with prognosis in oligometastatic prostate cancer has not been reported. And the effect of the CONUT score on the prognosis of prostate cancer was not compared with the platelet to lymphocyte ratio (PLR) and the neutrophil to lymphocyte ratio (NLR). A total of 94 patients who underwent surgery for oligometastatic prostate cancer from January 2015 to December 2017 were retrospectively analyzed.The appropriate cut-off values of CONUT, PLR, and NLR were determined by X-tail. CONUT scores were statistically significant for Gleason scores, T-stage, tumor margin, NLR, and PLR (P < 0.05). We evaluated the effect of CONUT scores on PSA progression-free survival. Univariate and multivariate analyses were performed to determine the independent predictors of CONUT scores. On univariate analysis, CONUT scores, NLR, and PLR were significantly associated with PSA progression-free survival (P < 0.05). Multivariate analysis showed that the CONUT score was an independent prognostic factor (P < 0.05). The present study indicates that the CONUT score is an independent prognostic factor for patients with oligometastatic prostate cancer. (C) 2019 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Oncology

Preoperative Nutritional Risk Index Predicts Recurrence of Oligometastatic Prostate Cancer in Patients Undergoing Cytoreductive Radical Prostatectomy

Yadong Guo, Ruiliang Wang, Wentao Zhang, Shiyu Mao, Yuan Wu, Ji Liu, Wenchao Ma, Zongtai Zheng, Junfeng Zhang, Xudong Yao, Yongzhen Liu

Summary: This study found that a high-risk NRI value is an independent prognostic factor for shorter PSA-PFS in OM-PC patients. The AUC value of the NRI score was higher than other conventional nutritional indicators, indicating its potential use as a new prognostic indicator for PSA-PFS.

NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2021)

Article Oncology

A Genomic-Clinicopathologic Nomogram for the Prediction of Lymph Node Invasion in Prostate Cancer

Zongtai Zheng, Shiyu Mao, Zhuoran Gu, Ruiliang Wang, Yadong Guo, Wentao Zhang, Xudong Yao

Summary: A genomic-clinicopathologic nomogram was developed to predict lymph node invasion in prostate cancer patients. The 37-gene-based SVM model showed optimal performance in both training and validation sets. Dysregulated expression of hub genes between PCa and LNI samples was validated, suggesting potential for further functional studies and mechanistic analyses.

JOURNAL OF ONCOLOGY (2021)

Article Oncology

Hsa_circ_0004296 inhibits metastasis of prostate cancer by interacting with EIF4A3 to prevent nuclear export of ETS1 mRNA

Shiyu Mao, Wentao Zhang, Fuhan Yang, Yadong Guo, Hong Wang, Yuan Wu, Ruiliang Wang, Niraj Maskey, Zongtai Zheng, Cheng Li, Wenchao Ma, Junfeng Zhang, Yang Yan, Xudong Yao

Summary: The study identified circ_0004296 as a circRNA associated with PCa metastasis through high-throughput RNA sequencing. Circ_0004296 was found to be downregulated in PCa tissues, blood, and urine, and its overexpression inhibited ETS1 expression, leading to the suppression of PCa metastasis. The downstream binding protein EIF4A3 was also identified as a potential therapeutic target for PCa.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)

Article Andrology

Effects of radical cystectomy, radiotherapy, and chemotherapy on the risk of long-term heart-specific death in bladder cancer patients

Fuhan Yang, Cheng Li, Yadong Guo, Yang Yu, Shiyu Mao, Ruiliang Wang, Wentao Zhang, Aihong Zhang, Xudong Yao

Summary: The study revealed that patients receiving different treatments for bladder cancer had varying risks of heart-specific death, with the highest risk observed in the RT group, especially among patients over 65 years of age. Patients in all age groups receiving RC, RT, or CT had higher heart-specific and overall mortality rates compared to the general population.

TRANSLATIONAL ANDROLOGY AND UROLOGY (2021)

Article Cell Biology

Causes of Death after Prostate Cancer Diagnosis: A PopulationBased Study

Yadong Guo, Xiaohui Dong, Shiyu Mao, Fuhan Yang, Ruiliang Wang, Wenchao Ma, Ji Liu, Cheng Li, Zongtai Zheng, Wentao Zhang, Aihong Zhang, Xudong Yao

Summary: This study examines the causes and risks of noncancer death in patients with prostate cancer during different follow-up periods after diagnosis. The results show that the largest proportion of noncancer deaths occur within 5 to 10 years after diagnosis, with cardiovascular and cerebrovascular diseases and chronic obstructive pulmonary disease being the most common causes. The risk of noncancer death is influenced by treatment, ethnicity, and staging differences.

OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2022)

Article Endocrinology & Metabolism

Recent Trends in the Incidence of Clear Cell Adenocarcinoma and Survival Outcomes: A SEER Analysis

Yadong Guo, Anil Shrestha, Niraj Maskey, Xiaohui Dong, Zongtai Zheng, Fuhan Yang, Ruiliang Wang, Wenchao Ma, Ji Liu, Cheng Li, Wentao Zhang, Shiyu Mao, Aihong Zhang, Shenghua Liu, Xudong Yao

Summary: This study comprehensively investigates the recent trends in the epidemiological and prognostic factors of clear cell adenocarcinoma (CCA). The results show that the incidence of CCA and the survival of these patients have improved over time, especially in grade IV CCA. This may be attributed to earlier diagnosis and improved treatment.

FRONTIERS IN ENDOCRINOLOGY (2022)

Article Biochemistry & Molecular Biology

Metabolic-associated signature and hub genes associated with immune microenvironment and prognosis in bladder cancer

Yadong Guo, Zongtai Zheng, Shiyu Mao, Fuhan Yang, Ruiliang Wang, Hong Wang, Ji Liu, Cheng Li, Qinwan Wang, Wentao Zhang, Xudong Yao, Shenghua Liu

Summary: This study aimed to investigate the relationship between metabolism and immune microenvironment in bladder cancer and construct a metabolic-associated signature for prognostic prediction. The findings suggest that high-risk bladder cancer patients have advanced clinicopathological features and poor survival outcomes, and exhibit lower response rates to anti-PD-L1 treatment. The downregulation of TST and S100A16 promotes invasion and migration of bladder cancer cells, affects immune cell infiltration and expression of PD-L1 and CD47.

MOLECULAR CARCINOGENESIS (2022)

Review Biochemistry & Molecular Biology

Urological cancer organoids, patients' avatars for precision medicine: past, present and future

Haotian Chen, Wentao Zhang, Niraj Maskey, Fuhan Yang, Zongtai Zheng, Cheng Li, Ruiliang Wang, Pengfei Wu, Shiyu Mao, Junfeng Zhang, Yang Yan, Wei Li, Xudong Yao

Summary: Urological cancers are common malignant tumors worldwide. Traditional two-dimensional cell cultures and animal models cannot fully simulate the complexity of tumors and their interactions with the surrounding environment. The emergence of three-dimensional organoid models provides a new solution for studying urological cancers but still faces some challenges.

CELL AND BIOSCIENCE (2022)

Review Endocrinology & Metabolism

Emerging roles and potential application of PIWI-interacting RNA in urological tumors

Jingcheng Zhang, Wentao Zhang, Yuchao Liu, Man Pi, Yufeng Jiang, Ailiyaer Ainiwaer, Shiyu Mao, Haotian Chen, Yuefei Ran, Shuwen Sun, Wei Li, Xudong Yao, Zhengyan Chang, Yang Yan

Summary: The piRNA is a small molecule, non-coding RNA with a length of 24-32nt. It was originally found in germ cells and is considered a regulator of germ cell function. It can interact with PIWI protein and play a role in gene transcription regulation and transposable factors silencing. Abnormal expression of piRNAs has been found in various cancer tissues and patient fluids, making them potential diagnostic tools, therapeutic targets, staging markers, and prognostic evaluation tools for cancer. This article reviews recent research on piRNA, focusing on its structural characteristics, production mechanism, applications, and role in urological tumors, providing valuable insights for the regulation of urological tumors by piRNA.

FRONTIERS IN ENDOCRINOLOGY (2023)

Review Multidisciplinary Sciences

Bladder cancer-associated microbiota: Recent advances and future perspectives

Wentao Zhang, Fuhan Yang, Shiyu Mao, Ruiliang Wang, Haotian Chen, Yuefei Ran, Shenghua Liu, Pengfei Wu, Yang Yan, Wei Li, Junfeng Zhang, Xudong Yao

Summary: Recent evidence suggests that the genitourinary microbiome plays a significant role in the development and progression of urological tumors, including bladder cancer. However, there is limited information available about the interaction between bladder cancer and the genitourinary microbiome, compared to the gut microbiota and gastrointestinal tumors. This expanding field merits further investigation for its potential impact on bladder cancer diagnosis, prevention, and treatment prospects.

HELIYON (2023)

Article Urology & Nephrology

Perioperative change of circulating tumor cells in cytoreductive radical prostatectomy for oligometastatic hormone-sensitive prostate cancer: the preliminary safety evidence from long-term oncologic outcomes

Niraj Maskey, Shiyu Mao, Guanjie Yang, Yadong Guo, Aimaitiaji Kadier, Jing Yuan, Jun Xie, Changcheng Guo, Bin Yang, Xudong Yao

Summary: This study aimed to assess the safety of cytoreductive radical prostatectomy (CRP) for patients with oligometastatic hormone-sensitive prostate cancer (omHSPC) by monitoring the perioperative change of circulating tumor cells (CTCs) and investigating its impact on long-term oncologic outcomes. The results showed that there was no significant difference in long-term oncologic outcomes between the perioperative CTC increase and non-increase groups, indicating that CRP potentially represents a safe procedure for the treatment of patients with omHSPC.

INTERNATIONAL UROLOGY AND NEPHROLOGY (2023)

Article Biochemistry & Molecular Biology

Can uric acid affect the immune microenvironment in bladder cancer? A single-center multi-omics study

Haotian Chen, Donghui Shi, Changfeng Guo, Wentao Zhang, Yadong Guo, Fuhan Yang, Ruiliang Wang, Junfeng Zhang, Zujun Fang, Yang Yan, Shiyu Mao, Xudong Yao

Summary: This study uncovered the role of uric acid in bladder cancer metabolism and immunotherapy. High uric acid levels were associated with worse prognosis and poor response to immunotherapy in bladder cancer patients. Experimental findings in a mouse model and multi-omic analysis revealed the impact of uric acid on tumor growth and immune cell alterations.

MOLECULAR CARCINOGENESIS (2023)

Article Oncology

Gender dimorphism in survival of patients with lymph node metastasis of bladder cancer

Yadong Guo, Zongtai Zheng, Wentao Zhang, Shiyu Mao, Fuhan Yang, Wei Li, Yang Yan, Xudong Yao

Summary: The effect of gender and metastasis sites on the prognosis of bladder cancer is assessed in this study. A gender-associated signature is identified and validated, and a radiomics signature is developed for predicting the gender-associated signature. These results provide additional evidence for individualized treatment in bladder cancer.

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2022)

Letter Urology & Nephrology

Long-term sexual dysfunction and hypotensive shock in a patient with a pheochromocytoma

Haotian Chen, Ziwei Zhang, Wentao Zhang, Fuhan Yang, Shiyu Mao, Yuan Wu, Junfeng Zhang, Yang Yan, Xudong Yao

INTERNATIONAL UROLOGY AND NEPHROLOGY (2022)

Article Oncology

Construction and Validation of a Novel Eight-Gene Risk Signature to Predict the Progression and Prognosis of Bladder Cancer

Ruiliang Wang, Zongtai Zheng, Shiyu Mao, Wentao Zhang, Ji Liu, Cheng Li, Shenghua Liu, Xudong Yao

Summary: By analyzing RNA-Sequence data and gene co-expression network, researchers established a novel eight-gene risk signature that can predict the progression and prognosis of bladder cancer patients. The study found that this signature was closely related to the malignant clinical features of BC.

FRONTIERS IN ONCOLOGY (2021)

Article Oncology

Using machine learning algorithms to predict the prognosis of advanced nasopharyngeal carcinoma after intensity-modulated radiotherapy

Dan Hu, Ying Wang, Genxin Ji, Yu Liu

Summary: This study constructed prognostic models for advanced NPC patients treated with IMRT using machine learning algorithms. Random forest (RF) showed the best predictive performance and identified the most important predictors. RF was proposed as a simple and accurate tool for evaluating the prognosis of advanced NPC patients.

CURRENT PROBLEMS IN CANCER (2024)

Article Oncology

Detection of circulating normal and tumor plasma cells in newly diagnosed patients of multiple myeloma and their associations with clinical and laboratory parameters

Leena Gupta, Pratibha Suku, Aishwarya Dash, Parveen Bose, Praveen Sharma, Nabhajit Mallik, Sreejesh Sreedharanunni, Neelam Varma, Aditya Jandial, Pankaj Malhotra, Man Updesh Singh Sachdeva

Summary: This study evaluated the load and characteristics of circulating tumor plasma cells (CTPCs) and circulating normal plasma cells (CNPCs) in newly diagnosed multiple myeloma patients using flow cytometry. Increased burden of CTPCs was associated with poor prognostic markers and poor response to therapy. CNPCs were lower in patients with thrombocytopenia and hypoalbuminemia.

CURRENT PROBLEMS IN CANCER (2024)